Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
906
-
Total 13F shares, excl. options
-
89,440,318
-
Shares change
-
-775,683
-
Total reported value, excl. options
-
$42,282,450,124
-
Value change
-
-$390,555,615
-
Put/Call ratio
-
158%
-
Number of buys
-
496
-
Number of sells
-
-395
-
Price
-
$473.14
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2021
1,075 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 906 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89,440,318 shares
of 104,986,330 outstanding shares and own 85.19% of the company stock.
Largest 10 shareholders include FMR LLC (10,935,989 shares), BlackRock Inc. (9,649,547 shares), VANGUARD GROUP INC (8,000,412 shares), Capital World Investors (6,184,120 shares), STATE STREET CORP (4,547,301 shares), WELLINGTON MANAGEMENT GROUP LLP (3,876,380 shares), JPMORGAN CHASE & CO (3,035,655 shares), LOOMIS SAYLES & CO L P (2,876,368 shares), ALLIANCEBERNSTEIN L.P. (2,077,251 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,610,190 shares).
This table shows the top 906 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.